The United Kingdom government has announced that it will add Bharat Biotech’s Covaxin to its list of approved coronavirus vaccines for tra...
The United Kingdom government has announced that it will add Bharat Biotech’s Covaxin to its list of approved coronavirus vaccines for travel to the country from 4 am on November 22.
The United Kingdom has announced that it will recognise all Covid-19 vaccines that are on the World Health Organization’s Emergency Use Listing, including Covaxin, from November 22.
This will mean that people who have been fully vaccinated with Covaxin will not have to take a pre-departure Covid-19 test, self-isolate on arrival in the United Kingdom, or need to take a test on the eighth day of their arrival.
The travellers will only need to pay for a lateral flow test for Covid-19 before the end of their second day of arrival.
Lateral flow tests involve taking samples from the nose and throat, and the results become clear in 15 to 30 minutes.
British High Commissioner to India Alex Ellis said that the development came as good news for Indian travellers to the United Kingdom.
More good news for 🇮🇳 travellers to 🇬🇧👇
— Alex Ellis (@AlexWEllis) November 8, 2021
From 22 November travellers fully vaccinated with a #COVID19 vaccine recognised by @WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield.https://t.co/UyJsryBd0O https://t.co/mZhaqRgB35
The United Kingdom’s Transport Secretary Grant Shapps said...
